Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 229.0 | 50 | |
N2645 | PH-797804 | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 150.5 | 48 | |
RA2708 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 38.0 | 52 | |
RA2708 | PH-797804 | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 29.0 | 27 | |
RA2159 | 2 | b-NGF | 24.0 | 40 | |||||||
N2645 | 2 | b-NGF | 164.5 | 66 | |||||||
RA2708 | 2 | b-NGF | 24.0 | 50 | |||||||
RA2159 | JNK-IN-8 | 3.0 | uM | 2 | b-NGF | 25.0 | 46 | ||||
RA2159 | PH-797804 | 0.6 | uM | 2 | b-NGF | 23.5 | 58 | ||||
N2645 | JNK-IN-8 | 3.0 | uM | 2 | b-NGF | 162.0 | 29 | ||||
N2645 | PH-797804 | 0.6 | uM | 2 | b-NGF | 111.0 | 46 | ||||
RA2708 | JNK-IN-8 | 3.0 | uM | 2 | b-NGF | 21.0 | 39 | ||||
RA2708 | PH-797804 | 0.6 | uM | 2 | b-NGF | 24.0 | 42 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | b-NGF | 27.0 | 49 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | b-NGF | 24.0 | 42 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | b-NGF | 121.5 | 30 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | b-NGF | 100.5 | 56 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | b-NGF | 22.0 | 36 | ||||
RA2708 | IKK16 | 2.0 | uM | 2 | b-NGF | 19.0 | 48 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | b-NGF | 26.0 | 43 | ||||
RA2159 | 2 | b-NGF | 24.0 | 45 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | b-NGF | 180.0 | 51 | ||||
N2645 | 2 | b-NGF | 177.5 | 48 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | b-NGF | 25.0 | 48 | ||||
RA2708 | 2 | b-NGF | 20.0 | 43 |